| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06834100 | Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison… | Infections | Recruiting |
| Not specified | |||
| NCT06880250 | Efficacy and Safety of Enzyme Replacement Therapy in Patients With Fabry Disease | Fabry Disease | Enrolling by Invitation |